Strategies for continued successful treatment of Alzheimer's disease: switching cholinesterase inhibitors.
Curr Med Res Opin. 2003.
PMID: 14687441
Review.
Search Page
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 2003 | 1 |
| 2018 | 1 |
| 2026 | 0 |
Search Results
2 results
Results by year
Citations
1
article
found by citation matching
Search results
Page 1
Strategies for continued successful treatment of Alzheimer's disease: switching cholinesterase inhibitors.
Curr Med Res Opin. 2003;19(8):707-14. doi: 10.1185/030079903125002450.
Curr Med Res Opin. 2003.
PMID: 14687441
Review.
Cholinesterase (ChE) inhibitors represent the standard therapeutic approach to the treatment of Alzheimer's disease (AD). ...Switching medications is a common therapeutic strategy within many drug classes across many clinica …
Cholinesterase (ChE) inhibitors represent the standard therapeutic approach to the treatment of Alzheimer's …
Strategies for Continued Successful Treatment in Patients with Alzheimer's Disease: An Overview of Switching Between Pharmacological Agents.
Curr Alzheimer Res. 2018;15(10):964-974. doi: 10.2174/1567205015666180613112040.
Curr Alzheimer Res. 2018.
PMID: 29895249
Free PMC article.
Review.
INTRODUCTION: Alzheimer's disease (AD) is the most common cause of dementia, characterized by a progressive decline in cognition and function. Current treatment options for AD include the cholinesterase inhibitors (ChEIs) donepezil, galan …
INTRODUCTION: Alzheimer's disease (AD) is the most common cause of dementia, characterized by a progressive decline in …
Cite